Breast Lesion Localization Methods Market of Non-palpable Tumor is Expected to Grow in the near Future

By -

The breast lesion localization methods market is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period.

(EMAILWIRE.COM, September 28, 2020 ) The report "Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025", is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period.

The overall market for breast lesion localization methods market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer. Furthermore, the demand for improved quality of care and growing awareness among patients about breast cancer screening also contributes to market growth. However, uncertainty in regulatory approval procedures may negatively affect the market.

Wire localization accounted for the largest share of the breast lesion localization methods market in 2020

Based on type, the breast lesion localization methods market is divided into wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2019. The large share of this segment is attributed to the increasing use of third-party independent quality controls due to their benefits such as longer shelf-lives and flexibility across different reagent lots, which help reduce the cost of operations.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35768623

The combined localization of non-palpable tumor and sentinel lymph node is expected to grow in the near future

By usage, the breast lesion localization methods market is segmented into tumor identification and sentinel lymph node identification.The sentinel lymph node identification segment is further divided by types of surgery into lumpectomy and mastectomy.The sentinel lymph node identification segment dominated thebreast lesion localization methods market in 2019.

The APAC market is projected to grow at the highest rate during the forecast period.

In 2019, the Asia Pacific held the largest share of the breast lesion localization methods market, in terms of volume. In addition to this, Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The rapidly increasing patient population and healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness about the importance of the early detection of breast cancer in several APAC countries are supporting the growth of the Asia Pacific breast lesion localization methods market.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=35768623

Key Players

The prominent players in the breast lesion localization methods market are Cianna Medical (US), Endomagnetics Ltd. (UK), and IZI Medical (US), Hologic, Inc. (US), Intra-Medical Imaging LLC (US), and IsoAid, LLC (US).

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more